A Study to Assess the Efficacy, Safety and Tolerability of VLS-01-Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (TRD)

OPENING SOON

Study Sponsored by atai Therapeutics, Inc.

This Phase 2, multicenter study will determine the efficacy, safety, and tolerability of short-term treatment with a VLS-01 transmucosal buccal film (VLS-01-BU) in patients with treatment resistant Major Depressive disorder (TRD) and will characterize the onset and durability of antidepressant effects of VLS-01-BU versus placebo.

Learn More

To learn about other open trials click the button below:

View Open Clinical Trials